Related Experiment Videos
Recurrence in early gastric cancer: a pathologic evaluation
Cancer
|July 1, 1980
Summary
Recurrence in early gastric carcinoma is often linked to residual disease or liver metastases. Preventing these requires complete resection and chemotherapy to combat hematogenous spread.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Pathology
Background:
- Early gastric carcinoma (EGC) necessitates understanding recurrence patterns for improved patient outcomes.
- Tumor recurrence significantly impacts survival rates in EGC patients.
Purpose of the Study:
- To investigate the causes of death in EGC cases.
- To analyze the relationship between recurrence patterns and mortality in EGC.
Main Methods:
- Retrospective analysis of 26 deaths among 220 EGC cases.
- Examination of gross appearance and histologic findings of recurring carcinomas.
- Review of patient records for causes of death and presence of double primary carcinomas.
Main Results:
- Seven patients died from disease-related causes, primarily due to residual carcinoma or liver metastases.
- Hematogenous metastasis, particularly to the liver, was a significant factor in recurrence.
- Eighteen patients died from other causes; five had non-gastric double primary carcinomas.
Conclusions:
- Preventing recurrence in EGC is crucial and involves ensuring complete tumor resection.
- Anticancer chemotherapy is vital for prophylaxis against hematogenous metastasis, especially to the liver.